Sutro Biopharma, Inc

(NASDAQ:STRO)

Latest On Sutro Biopharma, Inc (STRO):

Date/Time Type Description Signal Details
2023-05-15 15:17 ESTNewsSutro Biopharma GAAP EPS of -$0.85, revenue of $12.7MN/A
2023-05-03 15:49 ESTNewsSutro, Mersana jump after Immunogen data for ovarian cancer therapyN/A
2023-04-11 19:04 ESTNewsSutro: Too Little, Too Late For STRO-002, But Platform Is InterestingN/A
2023-03-31 10:48 ESTNewsSutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57MN/A
2023-03-22 01:51 ESTNewsSutro Biopharma stock slides as transferred to Equal Weight at Wells FargoN/A
2023-02-28 10:05 ESTNewsSutro Biopharma appoints Borgman as Chief Medical OfficerN/A
2022-12-20 18:43 ESTNewsVaxcyte acquires option from Sutro Biopharma to expand rights to make cell-free extractN/A
2022-11-08 19:34 ESTNewsSutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62MN/A
2022-08-16 14:27 ESTNewsSutro Biopharma: Partnership Progress Warrants ExposureN/A
2022-08-09 08:23 ESTNewsSutro Biopharma GAAP EPS of -$0.55, revenue of $28.1MN/A
2022-07-26 21:24 ESTNewsSutro to get $10M payment from Merck after first patient dosed in collaboration trialN/A
2022-06-28 10:31 ESTNewsSutro Biopharma soars ~50% after announcing worldwide strategic collaboration with Astellas PharmaN/A
2022-05-09 17:15 ESTNewsSutro Biopharma GAAP EPS of -$0.84 misses by $0.08, revenue of $5.89M misses by $4.57MN/A
2022-02-28 19:19 ESTNewsSutro Biopharma GAAP EPS of -$2.29 misses by $0.13, revenue of $61.88M beats by $0.16MN/A
2022-01-06 18:39 ESTNewsSutro at a 52-week low as analysts weigh in on safety data for cancer drugN/A
2022-01-06 02:58 ESTNewsSutro posts early-stage data for ovarian cancer drug indicating 33% ORRN/A
2021-12-27 20:30 ESTNewsSutro Bio inks licensing deal for STRO-002 in Greater ChinaN/A
2021-12-27 20:30 ESTNewsSutro; A Biotech To Watch With A Catalyst Rapidly ApproachingN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At 4th Annual Evercore ISI HealthCONx Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Piper Sandler 33rd Annual Virtual Healthcare Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Jefferies London Healthcare Conference - SlideshowN/A
2021-11-23 08:45 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-10 16:26 ESTNewsSutro Biopharma EPS misses by $0.02, misses on revenueN/A
2021-10-12 13:29 ESTNewsSutro Biopharma and BioNova ink collaboration agreement for STRO-001 in Greater ChinaN/A
2021-10-01 22:07 ESTNewsSutro Biopharma and Merck extend research term for cytokine derivative programN/A
2021-09-11 04:32 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Wells Fargo Healthcare ConferenceN/A
2021-08-18 17:50 ESTNewsSutro Biopharma nabs FDA Fast Track Designation for ovarian cancer therapyN/A
2021-08-09 15:28 ESTNewsSutro Biopharma reports Q2 resultsN/A
2021-07-22 02:42 ESTNewsSutro Biopharma initiated buy at H.C. Wainwright citing ADC candidatesN/A
2021-05-07 16:03 ESTNewsSutro Biopharma EPS misses by $0.04, beats on revenueN/A
2021-04-16 02:20 ESTNewsSutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - SlideshowN/A
2021-04-15 08:22 ESTNewsSutro Biopharma earns milestone payment from Merck collaborationN/A
2021-03-19 02:57 ESTNewsSutro Biopharma EPS misses by $1.07, revenue in-lineN/A
2021-03-03 12:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.14 to $29.43.Neutral
2021-02-24 14:49 ESTNewsBristol-Myers receives FDA’s orphan drug designation for multiple myeloma therapyN/A
2021-01-29 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $29.29 to $31.14.Buy
2021-01-22 08:39 ESTAnalyst RatingThe Analyst Target Price has increased from $28.57 to $29.29.Buy
2021-01-21 14:56 ESTNewsDosing underway in Sutro Biopharma's early-stage ovarian cancer trial with STRO-002N/A
2021-01-06 11:06 ESTNewsSutro: Leading Cell Free Protein Synthesis Company With Promising Early DataN/A
2020-12-15 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $27.57 to $28.57.Buy
2020-12-11 12:45 ESTAnalyst RatingThe Analyst Target Price has increased from $26.86 to $27.57.Buy
2020-12-09 07:03 ESTNewsSutro Biopharma (STRO) Investor Presentation - SlideshowN/A
2020-12-09 07:03 ESTNewsSutro Biopharma prices $126M public offeringN/A
2020-12-08 12:46 ESTNewsSutro Biopharma down after STRO-001 data in blood cancer studyN/A
2020-12-08 12:46 ESTNewsSutro Biopharma -4.6% after filing to offer 5M sharesN/A
2020-12-07 21:12 ESTAnalyst RatingThe Analyst Target Price has increased from $21.57 to $26.86.Buy
2020-12-04 12:27 ESTNewsSutro +23.5% as ovarian cancer drug study offers encouraging interim dataN/A
2020-12-04 09:03 ESTAnalyst RatingThe Analyst Target Price has increased from $21 to $21.57.Neutral
2020-11-28 06:08 ESTNewsSeeking Alpha Catalyst WatchN/A
2020-11-26 21:40 ESTFinancialsCompany financials have been released.Neutral

About Sutro Biopharma, Inc (STRO):

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO Quotes by TradingView

See Advanced Chart

General

  • Name Sutro Biopharma, Inc
  • Symbol STRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 182
  • Fiscal Year EndDecember
  • IPO Date2018-09-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sutrobio.com
View More

Valuation

  • Trailing PE 54.26
  • Price/Sales (Trailing 12 Mt.) 14.95
  • Price/Book (Most Recent Quarter) 4.48
  • Enterprise Value Revenue 18.27
  • Enterprise Value EBITDA 41.71
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.56
  • Profit Margin 28%
  • Operating Margin -134%
  • Return on Assets -16%
  • Return on Equity 7%
  • Revenue 45.75 million
  • Earnings Per Share $0.44
  • Revenue Per Share $1.62
  • Gross Profit -22876000
  • Quarterly Earnings Growth 45.2%
View More

Highlights

  • Market Capitalization 1.09 billion
  • EBITDA -36933000
  • PE Ratio -3.01
  • Analyst Target Price $29.43
  • Book Value Per Share $6.41
View More

Share Statistics

  • Shares Outstanding 45.61 million
  • Shares Float 34.47 million
  • % Held by Insiders 1111%
  • % Held by Institutions 88.44%
  • Shares Short 1.14 million
  • Shares Short Prior Month 1.03 million
  • Short Ratio 2.56
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.79
  • 52 Week High $28.3
  • 52 Week Low $6.91
  • 50 Day Moving Average 23.26
  • 200 Day Moving Average 18.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sutro Biopharma, Inc (STRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sutro Biopharma, Inc (STRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$17.82 million$0.45-$0.51188.74%
2020-06-302020-08-06$N/A$0.94-$0.64246.01%
2020-03-312020-05-11$7.15 million-$0.84-$0.69-21.99%
2019-12-312020-03-16$11.31 million-$0.64-$0.697.81%
2019-09-302019-11-08$12.28 million-$0.56-$0.6514.45%
2019-06-302019-08-14$10.53 million-$0.60-$0.623.41%
2019-03-312019-05-15$8.63 million-$0.62-$0.61-2.06%
2018-12-312018-12-31$19.09 million-$0.26-$0.6358.73%
2018-09-302018-11-14$7.84 million-$0.45-$0.8547.5%

Sutro Biopharma, Inc (STRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 19.36 million N/A 17.62 million N/A 16.9 million
Income Before Tax 17.14 million N/A -19.6 million -14.79 million -12.91 million
Selling General Administrative 9.08 million N/A 8.71 million 8.7 million 8.12 million
Gross Profit N/A N/A N/A -6.09 million 12.28 million
Ebit 20.42 million N/A -17.44 million -14.93 million -12.74 million
Operating Income -10.62 million N/A -19.18 million -14.93 million -12.74 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 17.82 million N/A 7.15 million 11.31 million 12.28 million
Cost of Revenue N/A N/A N/A 17.39 million N/A
Total Other Income Expense Net 29.78 million N/A N/A 138000 -177000
Net Income From Continuing Operations 17.14 million N/A -19.6 million -14.79 million -12.91 million
Net Income Applicable to Common Shares N/A 29.87 million -19.6 million -14.79 million -12.91 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 296000 N/A 41.64 million 9.99 million 10.48 million
Change to Liabilities N/A -5.89 million N/A -3.66 million -6.69 million
Total Cash Flow from Investing Activities N/A -57.14 million N/A 7.94 million 9.81 million
Net Borrowings N/A N/A N/A -1.5 million -1.5 million
Total Cash Flow from Financial Activities 17.27 million N/A 15.7 million -1.78 million -1.13 million
Change to Operating Activities N/A 1.92 million N/A 197000 444000
Change in Cash -121000 N/A 38.61 million -6.99 million -7.44 million
Total Cash from Operating Activities -17.69 million -12.5 million -18.73 million -13.16 million -16.12 million
Depreciation 967000 N/A 1.1 million 1.22 million 1.23 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables -2.38 million N/A -2.78 million 1.23 million -1.03 million
Other Cash Flow from Financing Activities N/A N/A N/A -327000 N/A
Change to Net Income N/A -43.44 million N/A 2.45 million 2.84 million
Capital Expenditures 2.98 million N/A 763000 2.05 million 667000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 63.12 million N/A 71.79 million 58.58 million 61.77 million
Total Stockholder Equity 244.12 million N/A 82.09 million 97.79 million 109.91 million
Other Current Liabilities 3.44 million N/A 352000 20.37 million 20.84 million
Total Assets 307.24 million N/A 153.88 million 156.37 million 171.68 million
Common Stock N/A 36000 23000 23000 23000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -168.33 million -185.47 million -215.34 million -195.75 million -180.96 million
Other Liabilities N/A 11.04 million N/A 16.74 million 20.41 million
Other Assets N/A 2.14 million 2.7 million 2.56 million 2.37 million
Cash 64.37 million N/A 43.57 million 4.96 million 11.95 million
Total Current Liabilities 29.91 million N/A 32.01 million 32.97 million 35.86 million
Other Stockholder Equity N/A 398000 28000 165000 223000
Property, Plant & Equipment N/A 11.27 million 9.53 million 9.63 million 8.52 million
Total Current Assets 292.3 million N/A 127.46 million 128.57 million 135.57 million
Long Term Investments N/A N/A 14.19 million 15.61 million 25.22 million
Net Tangible Assets N/A 206.76 million N/A 97.79 million 109.91 million
Short Term Investments 216.86 million N/A 71.83 million 112.9 million 113.21 million
Long Term Debt 24.41 million N/A 24.16 million 8.88 million 5.5 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.88 million N/A 5.84 million 5.58 million 4.55 million

Sutro Biopharma, Inc (STRO) Chart:

Sutro Biopharma, Inc (STRO) News:

Below you will find a list of latest news for Sutro Biopharma, Inc (STRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sutro Biopharma, Inc (STRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-152.50CALL0 0636.52TRUE00
2026-05-1550CALL0 0438.3TRUE00
2026-05-157.50CALL0 1337.37TRUE00
2026-05-15100CALL0 0269.91TRUE00
2026-05-1512.50CALL0 4219.18TRUE00
2026-05-15150CALL0 3178.36TRUE00
2026-05-1517.50CALL0 1156.7TRUE00
2026-05-15200CALL0 2146.67TRUE00
2026-05-1522.56CALL0 21138.21TRUE00
2026-05-15255CALL0 2118.57TRUE00
2026-05-15303.47CALL0 19104.1FALSE00
2026-05-15350CALL0 0125.8FALSE00
2026-05-152.50PUT0 10FALSE00
2026-05-1550PUT0 0808.8FALSE00
2026-05-157.50PUT0 140294.08FALSE00
2026-05-15100PUT0 14312.43FALSE00
2026-05-1512.50PUT0 328293.97FALSE00
2026-05-15150PUT0 2323.66FALSE00
2026-05-1517.50PUT0 5269.53FALSE00
2026-05-15200PUT0 3223.11FALSE00
2026-05-1522.50.35PUT0 10127.35FALSE00
2026-05-15250PUT0 1149.26FALSE00
2026-05-15300PUT0 0119.94TRUE00
2026-05-15350PUT0 0109.22TRUE00
2026-08-212.50CALL0 1304.99TRUE00
2026-08-2150CALL0 0207.52TRUE00
2026-08-217.50CALL0 0175.1TRUE00
2026-08-21100CALL0 3156.86TRUE00
2026-08-2112.50CALL0 0146.56TRUE00
2026-08-21150CALL0 2138.23TRUE00
2026-08-2117.511.2CALL0 6134.9TRUE00
2026-08-21200CALL0 16126.79TRUE00
2026-08-2122.511.9CALL0 3126.3TRUE00
2026-08-21250CALL0 3125.97TRUE00
2026-08-21300CALL0 6118.91FALSE00
2026-08-21350CALL0 2117.48FALSE00
2026-08-212.50PUT0 0974.54FALSE00
2026-08-2150PUT0 0394.1FALSE00
2026-08-217.50PUT0 0290.87FALSE00
2026-08-21100PUT0 2231.65FALSE00
2026-08-2112.50PUT0 4190.2FALSE00
2026-08-21150PUT0 0158.21FALSE00
2026-08-2117.50PUT0 1133.26FALSE00
2026-08-21200PUT0 0126.02FALSE00
2026-08-2122.50PUT0 0124.24FALSE00
2026-08-21256.2PUT0 5120.25FALSE00
2026-08-21300PUT0 0120.7TRUE00
2026-08-21350PUT0 0116.22TRUE00
2026-11-2012.50CALL0 0133.23TRUE00
2026-11-20150CALL0 0126.9TRUE00
2026-11-2017.50CALL0 0124.36TRUE00
2026-11-20200CALL0 1126.75TRUE00
2026-11-2022.513.6CALL0 0120.07TRUE00
2026-11-20250CALL0 0121.18TRUE00
2026-11-20300CALL0 0116.42FALSE00
2026-11-20357CALL0 6113.27FALSE00
2026-11-2012.50PUT0 1146.55FALSE00
2026-11-20150PUT0 0123.19FALSE00
2026-11-2017.50PUT0 1121.71FALSE00
2026-11-20200PUT0 2120.67FALSE00
2026-11-2022.50PUT0 0120.49FALSE00
2026-11-20250PUT0 1117.4FALSE00
2026-11-20300PUT0 0114.69TRUE00
2026-11-20350PUT0 0112.53TRUE00

Latest STRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST220$3.585
Jun 13, 2022 7:59 PM EST84$3.585
Jun 13, 2022 7:59 PM EST100$3.585
Jun 13, 2022 7:59 PM EST65$3.585
Jun 13, 2022 7:59 PM EST10$3.585

Sutro Biopharma, Inc (STRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2019-10-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1382101/000000000019014405/0000000000-19-014405-index.htm
2020-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000092189520001581/0000921895-20-001581-index.htm
2020-08-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000093583620000485/0000935836-20-000485-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060241/0001104659-18-060241-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060573/0001104659-18-060573-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920013796/0001104659-20-013796-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920019043/0001104659-20-019043-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920020195/0001104659-20-020195-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920021714/0001104659-20-021714-index.htm
2020-08-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920098064/0001104659-20-098064-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420418052437/0001144204-18-052437-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419006659/0001144204-19-006659-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008119/0001144204-19-008119-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008329/0001144204-19-008329-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1382101/000119312518295955/0001193125-18-295955-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/0001193125-18-322690-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/0001193125-18-326967-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1382101/000119312519262726/0001193125-19-262726-index.htm
2019-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1382101/000119312519265124/0001193125-19-265124-index.htm
2019-10-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312519266765/0001193125-19-266765-index.htm
2020-05-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520139053/0001193125-20-139053-index.htm
2020-05-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520140570/0001193125-20-140570-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052480/0001209191-18-052480-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052481/0001209191-18-052481-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052482/0001209191-18-052482-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052483/0001209191-18-052483-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052487/0001209191-18-052487-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052490/0001209191-18-052490-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052491/0001209191-18-052491-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052492/0001209191-18-052492-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052493/0001209191-18-052493-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052495/0001209191-18-052495-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052496/0001209191-18-052496-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052826/0001209191-18-052826-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052831/0001209191-18-052831-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052833/0001209191-18-052833-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052835/0001209191-18-052835-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052837/0001209191-18-052837-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052839/0001209191-18-052839-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052841/0001209191-18-052841-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052848/0001209191-18-052848-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052851/0001209191-18-052851-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058332/0001209191-18-058332-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058335/0001209191-18-058335-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006200/0001209191-19-006200-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006201/0001209191-19-006201-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006202/0001209191-19-006202-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006203/0001209191-19-006203-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006204/0001209191-19-006204-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006206/0001209191-19-006206-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006208/0001209191-19-006208-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038094/0001209191-19-038094-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038097/0001209191-19-038097-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038100/0001209191-19-038100-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038101/0001209191-19-038101-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038102/0001209191-19-038102-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038103/0001209191-19-038103-index.htm
2019-06-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039122/0001209191-19-039122-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039123/0001209191-19-039123-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002565/0001209191-20-002565-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002569/0001209191-20-002569-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005798/0001209191-20-005798-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005806/0001209191-20-005806-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005808/0001209191-20-005808-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005810/0001209191-20-005810-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005812/0001209191-20-005812-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005814/0001209191-20-005814-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035026/0001209191-20-035026-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035027/0001209191-20-035027-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035028/0001209191-20-035028-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035030/0001209191-20-035030-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035036/0001209191-20-035036-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035037/0001209191-20-035037-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035058/0001209191-20-035058-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000141588918001458/0001415889-18-001458-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459018029555/0001564590-18-029555-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459019010253/0001564590-19-010253-index.htm
2019-04-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010261/0001564590-19-010261-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010338/0001564590-19-010338-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013160/0001564590-19-013160-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013167/0001564590-19-013167-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019016067/0001564590-19-016067-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019019236/0001564590-19-019236-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019019255/0001564590-19-019255-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022125/0001564590-19-022125-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022611/0001564590-19-022611-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019023255/0001564590-19-023255-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019031883/0001564590-19-031883-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019031936/0001564590-19-031936-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019038415/0001564590-19-038415-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019041909/0001564590-19-041909-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/0001564590-19-042019-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020000514/0001564590-20-000514-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020008232/0001564590-20-008232-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020010890/0001564590-20-010890-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020010955/0001564590-20-010955-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020011175/0001564590-20-011175-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018532/0001564590-20-018532-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018684/0001564590-20-018684-index.htm
2020-05-0410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020020872/0001564590-20-020872-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020023689/0001564590-20-023689-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024242/0001564590-20-024242-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024736/0001564590-20-024736-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020028506/0001564590-20-028506-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/0001564590-20-029235-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020036997/0001564590-20-036997-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020037231/0001564590-20-037231-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/0001564590-20-042563-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020043014/0001564590-20-043014-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020050755/0001564590-20-050755-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020050851/0001564590-20-050851-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000158064219000779/0001580642-19-000779-index.htm
2019-10-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1382101/999999999519002305/9999999995-19-002305-index.htm

Sutro Biopharma, Inc (STRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sutro Biopharma, Inc (STRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1111%
Institutional Ownership: 8844%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-26WILLIAM J NEWELLCEOBuy25,252.00119,337.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2020-05-14ARTURO MD MOLINAChief Medical OfficerBuy6,451.007.7549,995.2512,083.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-09-25EDWARD C ALBINICFO and SecretaryBuy7,174.0013,556.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-25Anik ShabbirChief Technical Ops. OfficerBuy8,609.0014,241.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-08-19John Gordon FreundDirectorSell500,000.008.724,360,000.001,460,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-09-25LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,576.0016,583.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-05-14WILLIAM J NEWELLCEOBuy64,516.007.75499,999.00166,627.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-08-26Trevor HallamChief Scientific OfficerSell975.009.048,818.2916,790.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-07-27Trevor HallamChief Science OfficerSell975.008.067,858.2117,765.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-06-26Trevor HallamChief Science OfficerSell975.008.027,817.6518,740.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-09-25WILLIAM J NEWELLCEOBuy25,252.00191,879.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2018-10-01Daniel H PetreeDirectorSell122.0015.001,830.00192.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-05-26Trevor HallamChief Science OfficerSell975.0010.009,753.3219,715.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-04-27Trevor HallamChief Science OfficerSell2.0011.1922.3820,690.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-09-25ARTURO MD MOLINAChief Medical OfficerBuy8,609.0020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-04-27Trevor HallamChief Science OfficerSell973.009.419,160.5020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-03-26Trevor HallamChief Science OfficerSell975.009.699,452.5321,665.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-02-26Trevor HallamChief Science OfficerSell975.0010.4710,207.2822,640.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-01-27Trevor HallamChief Science OfficerSell975.0010.5110,250.3723,615.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2019-12-26Trevor HallamChief Science OfficerSell975.0011.0810,802.2224,590.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2019-11-26Trevor HallamChief Science OfficerSell975.0010.6810,410.2725,565.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-10-28Trevor HallamChief Science OfficerSell975.009.989,726.1126,540.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy11,019.0026,819.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2018-10-01Merck & Co., Inc.10% Share HolderBuy666,666.0015.009,999,990.002,723,509.00https://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2020-09-28Trevor HallamChief Scientific OfficerSell975.0010.2610,006.7227,530.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy11,019.0027,809.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy6,887.0029,896.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-02-12Daniel H PetreeDirectorBuy3,030.005.0915,422.703,030.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy6,887.0030,886.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2018-10-01Daniel H PetreeDirectorBuy314.005.811,824.34314.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-10-05Trevor HallamChief Scientific OfficerBuy9,182.004.3640,033.5236,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-05Trevor HallamChief Scientific OfficerSell16,751.0015.00251,265.0036,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2019-09-06Daniel H PetreeDirectorBuy826.005.094,204.343,856.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2020-11-05Trevor HallamChief Scientific OfficerBuy16,751.004.3673,034.3653,463.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2020-09-18John Gordon FreundDirectorSell400,000.0012.004,800,000.00560,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2019-08-29LINDA A FITZPATRICKChief People & Comm. OfficerBuy826.005.094,204.34826.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-26LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,575.008,401.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-26Anik ShabbirChief Technical Ops. OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-26ARTURO MD MOLINAChief Medical OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-26EDWARD C ALBINICFO and SecretaryBuy7,174.008,862.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2020-05-14LINDA A FITZPATRICKChief People & Comm. OfficerBuy3,225.007.7524,993.759,007.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-09-11John Gordon FreundDirectorSell500,000.0010.005,000,000.00960,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm